Unknown

Dataset Information

Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization.


ABSTRACT:

Background

Abnormal regulation of angiogenesis in tumors results in the formation of vessels that are necessary for tumor growth, but compromised in structure and function. Abnormal tumor vasculature impairs oxygen and drug delivery and results in radiotherapy and chemotherapy resistance, respectively. Alpha particles are extraordinarily potent, short-ranged radiations with geometry uniquely suitable for selectively killing neovasculature.

Methodology and principal findings

Actinium-225 ((225)Ac)-E4G10, an alpha-emitting antibody construct reactive with the unengaged form of vascular endothelial cadherin, is capable of potent, selective killing of tumor neovascular endothelium and late endothelial progenitors in bone-marrow and blood. No specific normal-tissue uptake of E4G1

SUBMITTER: Singh Jaggi J 

PROVIDER: S-EPMC1801076 | biostudies-literature | 2007 Mar

REPOSITORIES: biostudies-literature